Exosomes of immune cell origin and their therapeutic potential for tumors
Authors:
Open Access
Abstract
Exosomes are nanoscale membrane vesicles identified by electron microscopy in 1946. They are approximately 30–150 nm in size. Originally, exosomes were thought to be used to eliminate excess components from cells to maintain their normal physiology. Later, it was found that the function and targeting of specific cellular components in exosomes have important implications for the regulation of cellular communication. In the last few years, exosomes have been linked to tumors, infections, and other diseases. New advances in cancer immunotherapy have occurred as a result of the identification of exosomes of immune cell origin, expanding the existing anticancer immune response. This article details exosomes derived from dendritic cells, T lymphocytes (CD4+ T cells, CD8+ T cells, and CAR‐T cells), natural killer cells, and their promising applications in tumor therapy.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (82322055, 82272792, 31970882, 81903140, 82041012, 92169115)
- Shanghai Rising-Star Program (23QA1405800)
This publication has 108 references indexed in Scilit:
- CAR‐T‐cell products in solid tumors: Progress, challenges, and strategiesInterdisciplinary Medicine, 2024
- Micro‐to‐Nano Oncolytic Microbial System Shifts from Tumor Killing to Tumor Draining Lymph Nodes Remolding for Enhanced ImmunotherapyAdvanced Materials, 2023
- Using natural killer cell‐derived exosomes as a cell‐free therapy for leukemiaHematological Oncology, 2022
- Human T lymphocytes at tumor sitesSeminars in Immunopathology, 2022
- Cell‐Based Delivery Systems: Emerging Carriers for ImmunotherapyAdvanced Functional Materials, 2021
- miR‐3607, a biomarker of hepatocellular carcinoma invasion and aggressiveness: Its relationship with epithelial‐mesenchymal transition processIUBMB Life, 2020
- Recent advances and challenges in the recovery and purification of cellular exosomesElectrophoresis, 2019
- Therapeutic Cancer Vaccines: How Much Closer Are We?BioDrugs, 2017
- Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological FluidsCurrent Protocols in Cell Biology, 2006
- Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: Selective externalization of the receptorCell, 1983